Autoantibody-negative insulin-dependent Diabetes after COVID-19

preprint OA: gold CC-BY-4.0
📄 Open PDF Full text JSON View at publisher

Abstract

Here we report the manifestation of insulin dependent diabetes after a COVID-19 infection in the absence of typical autoantibodies for type 1 diabetes. A 19-year-old Caucasian male subject presented to our emergency department with diabetic ketoacidosis (DKA). C-peptide levels accounted to 0.62µg/L in the presence of blood glucose concentrations of 30.6 mmol/L (552 mg/dL). The patient´s case history revealed a COVID-19 disease 6-8 weeks prior to admission. This is of interest, since COVID-19 internalization into host cells is mediated via Angiotensin-converting enzyme 2 (ACE2) [1] , a transmembrane glycoprotein which amongst others is crucial for β-cell homeostasis and function [2,3,4] . Detailed laboratory testing was performed, revealing no serum-antibodies against islet-cells (ICA), glutamic acid decarboxylase (GAD65-AA), tyrosine phosphatase (IA-2-AA), insulin (IAA) and zinc-transport-8 (ZnT8-AA), but against COVID-19. Hence, this is a presentation of an insulin-dependent diabetes mellitus in the absence of markers of autoimmunity, which might suggest direct cytolytic effects of COVID-19 on pancreatic β-cells presumably mediated via ACE2.
Full text 59,284 characters · extracted from preprint-html · click to expand
Autoantibody-negative insulin-dependent Diabetes after COVID-19 | Research Square window.SnipcartSettings = { analytics: { enabled: false } }; (function() { var accessVector = localStorage.getItem('access_vector') || ''; window.dataLayer = window.dataLayer || []; if (accessVector) { window.dataLayer.push({ user: { profile: { profileInfo: { snid: accessVector } } } }); } })(); (function(w,d,s,l,i){w[l]=w[l]||[];w[l].push({'gtm.start':new Date().getTime(),event:'gtm.js'});var f=d.getElementsByTagName(s)[0],j=d.createElement(s),dl=l!='dataLayer'?'&l='+l:'';j.async=true;j.src='https://www.googletagmanager.com/gtm.js?id='+i+dl;f.parentNode.insertBefore(j,f);})(window,document,'script','dataLayer','GTM-K279D39R'); Browse Preprints In Review Journals COVID-19 Preprints AJE Video Bytes Research Tools Research Promotion AJE Professional Editing AJE Rubriq About Preprint Platform In Review Editorial Policies Our Team Advisory Board Help Center Sign In Submit a Preprint Cite Share Download PDF Short Report Autoantibody-negative insulin-dependent Diabetes after COVID-19 Tim Hollstein, Juliane Schulz, Andreas Glück, Dominik M Schulte, and 3 more This is a preprint; it has not been peer reviewed by a journal. https://doi.org/ 10.21203/rs.3.rs-39343/v1 This work is licensed under a CC BY 4.0 License Status: Posted Version 1 posted You are reading this latest preprint version Abstract Here we report the manifestation of insulin dependent diabetes after a COVID-19 infection in the absence of typical autoantibodies for type 1 diabetes. A 19-year-old Caucasian male subject presented to our emergency department with diabetic ketoacidosis (DKA). C-peptide levels accounted to 0.62µg/L in the presence of blood glucose concentrations of 30.6 mmol/L (552 mg/dL). The patient´s case history revealed a COVID-19 disease 6-8 weeks prior to admission. This is of interest, since COVID-19 internalization into host cells is mediated via Angiotensin-converting enzyme 2 (ACE2) [1] , a transmembrane glycoprotein which amongst others is crucial for β-cell homeostasis and function [2,3,4] . Detailed laboratory testing was performed, revealing no serum-antibodies against islet-cells (ICA), glutamic acid decarboxylase (GAD65-AA), tyrosine phosphatase (IA-2-AA), insulin (IAA) and zinc-transport-8 (ZnT8-AA), but against COVID-19. Hence, this is a presentation of an insulin-dependent diabetes mellitus in the absence of markers of autoimmunity, which might suggest direct cytolytic effects of COVID-19 on pancreatic β-cells presumably mediated via ACE2. Endocrinology & Metabolism type 1 diabetes COVID-19 Introduction The recent COVID-19 (Sars-CoV-2) pandemic represents a worldwide health crisis causing severe illness and death especially in subjects with cardiovascular and metabolic abnormalities [5,6] . Interestingly, it has been shown that COVID-19 enters human cells via Angiotensin-converting-enzyme 2 (ACE2), a transmembrane glycoprotein with proteolytic activity also found in pancreatic β-cells [1,2,3,4] . Therefore, we have recommended a careful management of patients with diabetes and to monitor for new onset diabetes during the pandemic [7] . Indeed, patients were reported in Asia with acute diabetic ketoacidosis associated with COVID-19 disease [8] .The exact time course, causal relationship and presence or absence of autoantibodies was however not provided. Case Presentation Here we present a 19-year-old Caucasian male subject submitted to our emergency department with abnormal fatigue, exhaustion, and 12 kg weight loss within several weeks. He exhibited increased polydipsia of approx. 6 liter per day, nycturia (2-3x per night), and an intermittent postprandial left-sided flank pain. No fever episodes and no typical chest pain were reported. Laboratory testing in our emergency department revealed a DKA with a blood pH of 7.1, a blood glucose concentration of 30.6 mmol/L (552 mg/dL), reduced serum C-peptide levels of 0.62 µg/L (normal range: 1.1–4.4), a hemoglobin A1c of 16,8%, as well as positive urinary ketones and glucosuria. Type 1 diabetes was assumed. The family history revealed a maternal cousin with type 1 diabetes and a maternal grandmother with type 2 diabetes. However, the immunological examination yielded absence of serum-autoantibodies against islet-cells (ICA), glutamic acid decarboxylase (GAD65), tyrosine phosphatase (IA-2), insulin (IAA) and zinc-transport-8 (ZnT8) in the affected patient (Tab. 1). The patient further reported that he had an asymptomatic COVID-19 (Sars-CoV-2) infection 6-8 weeks before when returning from vacations in Austria with his family. On April 29 th 2020, he was tested positive for COVID-19 (Sars-CoV-2) IgG but not IgM indicating a previous COVID-19 infection. The patient needed treatment on the intensive care unit for 3 days for re-compensating DKA using intravenous insulin therapy according to international guidelines. At day 4, he was transferred to the endocrine ward and subcutaneous insulin therapy was initiated. In the course of the next days, blood glucose levels stabilized to 8.4 to 10.2 mmol/L (151 to 183 mg/dL). The patient received an educational program according to guidelines for type 1 diabetes management. He was discharged from hospital in good condition after 10 days. Discussion It is known for several years that corona like viruses enter human cells via binding to membrane bound proteases [1] . For example, the Middle East Respiratory Syndrome virus (MERS-CoV), responsible for an outbreak of acute respiratory syndrome, has been shown to use dipeptidylpeptidase (DPP4)-4, a protease known to be involved in the regulation of the incretin system [9] . Recently, it has been demonstrated in a functional assay, that ACE2 acts as the major binding partner for COVID-19 (Sars-CoV-2) spike glycoprotein mediating host cell internalization [10] . ACE2 is widely expressed in eukaryotic cells membranes including those of pancreatic β-cells [2] . Using a high-fat diet mouse model it has been shown that β-cell dedifferentiation is accompanied by ACE2 reduction [2] . ACE2 deletion in NOD mice resulted in hyperglycemia, decreased β-cell insulin content and increased β-cell oxidative stress [3] . In addition, ACE2 deficiency reduced β-cell mass and impairs β-cell proliferation in obese C57BL/6 mice [4] , overall suggesting this glycoprotein to be important for β-cell homeostasis. Finally, it is currently under debate, that ACE2 is important for intra-islet paracrine mechanisms in the communication of α and β-cells [3] . The hallmark in the pathology of classical type 1 diabetes is the β-cell destruction caused by a complex autoimmune process [11] . Environmental factors are suspected to be responsible, i.e. activating the immune system by reduction in gut microbiota, by early introduction to fruit or cow milk during childhood, by gluten, by toxins and especially by viruses [12] . Interestingly, besides inducing autoimmunity, some viruses like Enteroviruses might also exert direct cytolytic effects on pancreatic β-cell [13] . The patient reported here presented several weeks after a viral infection with a severe DKA with a profound loss of β-cell function. However, in contrast to the general idea that viral infections indirectly affect pancreatic β-cells by triggering autoimmunity, the absence of five typical antibodies in our patient might argue against classical autoimmune type 1 diabetes. Given the fact that ACE2 is expressed on pancreatic β-cells and ACE2 is the main receptor for COVID-19 (Sars-CoV-2) internalization we would like to propose a direct cytolytic β-cell damage due to COVID-19 (Sars-CoV-2) resulting in an insulin-depended diabetes without a classical autoimmune pathology in our patient. This assumption is supported by a recent mechanistic study demonstrating that adult human pancreatic alpha and beta cells are permissive to Sars-CoV-2 pseudo-entry virus and Sars-CoV-2 virus infection [14] . Furthermore, Sars-CoV-2 infection of pancreatic endocrine cells resulted in robust chemokine induction as seen in Covid-19 patients and upregulation of markers of cell death [14] . Despite a tremendous progress in biomedical research during the last centuries, the complex immunopathology of type 1 diabetes is still not elusively understood. A detailed understanding in the induction and progression of pancreatic β-cell failure, however, is crucial to develop novel innovative therapies to prevent and/or cure this important metabolic disease. In that regard, the detailed examination of patients developing β-cell failure and insulin-dependent diabetes after a COVID-19 infection in the future might yield novel insight into the yet unknown role of ACE2 in β-cell function and also possible virus induced cytolytic processes in type 1 diabetes development. Thus, a global registry has been launched to provide a systematic platform for collecting and analyzing these patients [15] . It will be critical to explore the frequency, severity and duration of these complications and to explore more deeply the mechanisms in primary human tissue. However, giving the fact that five different antibodies were tested negative our findings clearly suggest that diabetologists need to be aware of the possibility of an insulin dependent diabetes as an acute complication in COVID-19 (Sars-CoV-2) infected patients. Research Design and Methods The patient reported here was treated at the Intensive Care Unit as well as the Division of Endocrinology, Diabetes and Clinical Nutrition at the Department of Medicine 1 at the University of Kiel, Germany. All authors were directly involved in the treatment of the patient. The patient provided written informed consent for the information presented in this Case Report to be published. Patient care and research were conducted in compliance with the Case Report guidelines and the Declaration of Helsinki. Blood and urine samples (including autoantibodies against islet cells, GAD65, IA-2, insulin and ZnT8 in serum) were analyzed at the Department of Clinical Chemistry and Laboratory Medicine of the University of Kiel, Germany. Antibodies against COVID-19 (Sars-CoV-2) were determined by an external laboratory using the EDI™ Novel Coronavirus COVID-19 IgG ELISA Kit (Epitope Diagnostics, San Diego, USA). Declarations Acknowledgments: Author contributions: T.H. took cared of the patient on the ward and wrote the manuscript. D.M.S. took care of the patient in the emergency room and wrote the manuscript. A.G. took care of the patient on the intensive care unit and edited the manuscript, S.S. took care of the patient in the emergency room and wrote the manuscript. S.R.B. critically reviewed the case and wrote the manuscript. M.L. took care of the patient on the ward and wrote the manuscript. Statement of guarantor: Conflict-of-interest: Authors have no relevant conflict of interest to disclose. References [1] Hoffmann M, Kleine-Weber H, Schroeder S, Krüger N, Herrler T, Erichsen S, Schiergens TS, Herrler G, Wu NH, Nitsche A, Müller MA, Drosten C, Pöhlmann S. SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor. Cell . 2020, 181 :271-280.e8 [2] Xuan X, Gao F, Ma X, Huang C, Wang Y, Deng H, Wang S, Li W, Yuanet L, Activation of ACE2/angiotensin (1–7) attenuates pancreatic β cell dedifferentiation in a high-fat-diet mouse model, Metabolism 2018, 81 :83-96 [3] Roca-Ho H, Palau V, Gimeno J, Pascual J, Soler MJ, Riera M, Angiotensin-converting enzyme 2 influences pancreatic and renal function in diabetic mice, Lab Invest, 2020, doi.org/10.1038/s41374-020-0440-5 [4] Shoemaker R, Yiannikouris F, Thatcher S, Cassis L: ACE2 deficiency reduces beta-cell mass and impairs beta-cell proliferation in obese C57BL/6 mice. Am J Physiol Endocrinol Metab, 2015, 309 :E621-631. [5] Velavan, T., Meyer, C. The COVID-19 epidemic. Tropical medicine & international health , 2020, 3 :278–280. [6] Tay MZ, Poh CM, Renia L, MacAry PA, Ng LFP: The trinity of COVID-19: immunity, inflammation and intervention. Nat Rev Immunol . 2020 [epub ahead of print]. doi: 10.1038/s41577-020-0311-8 [7] Bornstein SR, Rubino F, Khunti K, Mingrone G, Hopkins D, Birkenfeld AL, Boehm B, Amiel S, Holt RIG, Skyler JS, DeVries JH, Renard E, Eckel RH, Zimmet P, Alberti KG, Vidal J, Geloneze B, Chan JC, Ji L, Ludwig B: Practical recommendations for the management of diabetes in patients with COVID-19. Lancet Diabetes Endocrinol . 2020, 8 : 546–550. doi: 10.1016/S2213-8587(20)30152-2. [8] Chee YJ, Huey Ng SJ, Yeoh E: Diabetic ketoacidosis precipitated by Covid-19 in a patient with newly diagnosed diabetes mellitus. Diabetes Res Clin Pract . 2020; 164 : 108166. Published online 2020 Apr 24. doi: 10.1016/j.diabres.2020.108166 [9] Fleischer B. CD26: a surface protease involved in T-cell activation. Immunol Today . 1994, 15 :180–184. [10] Letko M., Marzi A., Munster V. Functional assessment of cell entry and receptor usage for SARS-CoV-2 and other lineage B betacoronaviruses. Nat Microbiol . 2020, 5 :562–569. [11] Saberzadeh-Ardestani B, Karamzadeh R, Basiri M, Hajizadeh-Saffar E, Farhadi A, Shapiro AMJ, Tahamtani Y, Baharvand H: Type 1 Diabetes Mellitus: Cellular and Molecular Pathophysiology at A Glance. Cell J , 2018, 20: 294-301. [12] Knip M, Simell O: Environmental triggers of type 1 diabetes. Cold Spring Harb Perspect Med, 2012, 2:a007690. [13] Rodriguez-Calvo T, Sabouri S, Anquetil F, von Herrath MG: The viral paradigm in type 1 diabetes: Who are the main suspects? Autoimmun Rev , 2016, 15 :964-969. [14] Yang L, Han Y, Nilsson-Payant BE, Gupta V, Wang P, Duan X, Tang X, Zhu J, Zhao Z, Jaffré F, Tuo Zhang, Kim TW, Harschnitz O, Redmond D, Houghton S, Liu C, Naji A, Ciceri G, Guttikonda S, Bram Y, Nguyen DHT, Cioffi M, Chandar V, Hoagland DA, Huang Y, Xiang J, Wang H, Lyden D, Borczuk A, Chen HJ, Studer L, Pan FC, Ho DD, tenOever BR, Evans T, Schwartz RE, Chen S: A Human Pluripotent Stem Cell-based Platform to Study SARS-CoV-2 Tropism and Model Virus Infection in Human Cells and Organoids. Cell Stem Cell . doi: 10.1016/j.stem.2020.06.015 [15] Rubino F, Amiel SA, Zimmet P, Alberti G, Bornstein SR, Eckel RH, Mingrone G, Boehm B, Cooper ME, Chai Z, Del Prato S, Ji L, Hopkins D, Herman WH, Khunti K, Mbanya JC, Renard E: New-Onset Diabetes in Covid-19. N Engl J Med . 2020: NEJMc2018688. Published online 2020 Jun 12. doi: 10.1056/NEJMc2018688 Tables Table 1 – Immune diagnostic Result Reference range GAD65-AA < 5 IU/mL < 10 IA-2-AA < 10 IU/mL < 10 IC-AA negative negative I-AA < 0.1 IU/mL < 0.4 ZnT8-AA < 10 IU/mL < 15 COVID-19 (Sars-Cov-2) IgG positive negative COVID-19 (Sars-Cov-2) IgM negative negative I-AA, insulin autoantibodies; IC-AA, islet-cell autoantibodies; GAD65-AA, glutamic acid decarboxylase autoantibodies; IA-2-AA, tyrosine phosphatase autoantibodies; ZnT8-AA, zinc-transport-8 autoantibodies. Cite Share Download PDF Status: Posted Version 1 posted You are reading this latest preprint version Research Square lets you share your work early, gain feedback from the community, and start making changes to your manuscript prior to peer review in a journal. As a division of Research Square Company, we’re committed to making research communication faster, fairer, and more useful. We do this by developing innovative software and high quality services for the global research community. Our growing team is made up of researchers and industry professionals working together to solve the most critical problems facing scientific publishing. Also discoverable on Platform About Our Team In Review Editorial Policies Advisory Board Help Center Resources Author Services Accessibility API Access RSS feed Manage Cookie Preferences © Research Square 2026 | ISSN 2693-5015 (online) Privacy Policy Terms of Service Do Not Sell My Personal Information {"props":{"pageProps":{"initialData":{"identity":"rs-39343","acceptedTermsAndConditions":true,"allowDirectSubmit":true,"archivedVersions":[],"articleType":"Short Report","associatedPublications":[],"authors":[{"id":748598,"identity":"2193035e-987f-4725-b19e-51f0cb7c5b1e","order_by":0,"name":"Tim Hollstein","email":"","orcid":"","institution":"University of Kiel","correspondingAuthor":false,"submittingAuthor":false,"prefix":"","firstName":"Tim","middleName":"","lastName":"Hollstein","suffix":""},{"id":748599,"identity":"d398d2f3-1584-4d80-9af5-0aca4dc0105b","order_by":1,"name":"Juliane Schulz","email":"","orcid":"","institution":"University of Kiel","correspondingAuthor":false,"submittingAuthor":false,"prefix":"","firstName":"Juliane","middleName":"","lastName":"Schulz","suffix":""},{"id":748600,"identity":"bd0e5d23-ff25-4dd1-bc1c-17000a4154a7","order_by":2,"name":"Andreas Glück","email":"","orcid":"","institution":"University of Kiel","correspondingAuthor":false,"submittingAuthor":false,"prefix":"","firstName":"Andreas","middleName":"","lastName":"Glück","suffix":""},{"id":748601,"identity":"124f515c-9f73-4f36-9ce4-b00553a81c1b","order_by":3,"name":"Dominik M Schulte","email":"","orcid":"","institution":"University of Kiel","correspondingAuthor":false,"submittingAuthor":false,"prefix":"","firstName":"Dominik","middleName":"M","lastName":"Schulte","suffix":""},{"id":748602,"identity":"4f6fc4d5-6420-4f2e-8aad-9938860a8ae3","order_by":4,"name":"Stefan Schreiber","email":"","orcid":"","institution":"University of Kiel","correspondingAuthor":false,"submittingAuthor":false,"prefix":"","firstName":"Stefan","middleName":"","lastName":"Schreiber","suffix":""},{"id":748603,"identity":"b2842826-393c-4189-8c1b-b335ed94628c","order_by":5,"name":"Stefan R Bornstein","email":"","orcid":"","institution":"University of Dresden","correspondingAuthor":false,"submittingAuthor":false,"prefix":"","firstName":"Stefan","middleName":"R","lastName":"Bornstein","suffix":""},{"id":748604,"identity":"7b46fe98-ec2e-48e2-a467-ab756906f62d","order_by":6,"name":"Matthias Laudes","email":"data:image/png;base64,iVBORw0KGgoAAAANSUhEUgAAAZAAAAAyAQMAAABI0h/eAAAABlBMVEX///8AAABVwtN+AAAACXBIWXMAAA7EAAAOxAGVKw4bAAABAElEQVRIiWNgGAWjYJACZgYDIMkOxDwMDHJAgo0BhPBoYGwGa2GGaDEmUgsDQktiAyEtuu3njz8uKLCzZ2BmfibxpqIufcOZ488eMJTZ4NRidiaZsXmGQXJiAzObmeScM4dzN5ztMTdgOJeGW8sBoBYeA+YEoMPMpHnbDuRuOM/DJsHYdhi3lvOPQVrqgQ5j/ybN+68u3eA8+zOglv+4tdwA23KYsYGZB2hLA3OCwdkGM6CWA3i0PDaczWNwPLGNmafYcs6xw4Yzz5wxk0g4l4zHYYkPPvP8qbbnZ2/feONNTZ0835n0ZxIfyuxwaoED1IhIIKxhFIyCUTAKRgEeAAB3q0zEOsJgkAAAAABJRU5ErkJggg==","orcid":"","institution":"University of Kiel","correspondingAuthor":true,"submittingAuthor":false,"prefix":"","firstName":"Matthias","middleName":"","lastName":"Laudes","suffix":""}],"badges":[],"createdAt":"2020-07-01 12:24:04","currentVersionCode":1,"declarations":"","doi":"10.21203/rs.3.rs-39343/v1","doiUrl":"https://doi.org/10.21203/rs.3.rs-39343/v1","draftVersion":[],"editorialEvents":[],"editorialNote":"","failedWorkflow":false,"files":[{"id":13547740,"identity":"69cef21b-aa87-4c6e-8603-d75bc9b1fa9c","added_by":"auto","created_at":"2021-09-17 02:14:56","extension":"pdf","order_by":0,"title":"","display":"","copyAsset":false,"role":"manuscript-pdf","size":202129,"visible":true,"origin":"","legend":"","description":"","filename":"manuscript.pdf","url":"https://assets-eu.researchsquare.com/files/rs-39343/v1/a32959d4-db3a-42cf-8ca1-fe42ae60df8b.pdf"}],"financialInterests":"","formattedTitle":"\u003cp\u003eAutoantibody-negative insulin-dependent Diabetes after COVID-19\u003c/p\u003e","fulltext":[{"header":"Introduction","content":"\u003cp\u003eThe recent COVID-19 (Sars-CoV-2) pandemic represents a worldwide health crisis causing severe illness and death especially in subjects with cardiovascular and metabolic abnormalities \u003csup\u003e[5,6]\u003c/sup\u003e. Interestingly, it has been shown that COVID-19 enters human cells via Angiotensin-converting-enzyme 2 (ACE2), a transmembrane glycoprotein with proteolytic activity also found in pancreatic \u0026beta;-cells \u003csup\u003e[1,2,3,4]\u003c/sup\u003e. Therefore, we have recommended a careful management of patients with diabetes and to monitor for new onset diabetes during the pandemic \u003csup\u003e[7]\u003c/sup\u003e. Indeed, patients were reported in Asia with acute diabetic ketoacidosis associated with COVID-19 disease \u003csup\u003e[8]\u003c/sup\u003e.The exact time course, causal relationship and presence or absence of autoantibodies was however not provided.\u003c/p\u003e"},{"header":"Case Presentation","content":"\u003cp\u003eHere we present a 19-year-old Caucasian male subject submitted to our emergency department with abnormal fatigue, exhaustion, and 12 kg weight loss within several weeks. He exhibited increased polydipsia of approx. 6 liter per day, nycturia (2-3x per night), and an intermittent postprandial left-sided flank pain. No fever episodes and no typical chest pain were reported. Laboratory testing in our emergency department revealed a DKA with a blood pH of 7.1, a blood glucose concentration of 30.6 mmol/L (552 mg/dL), reduced serum C-peptide levels of 0.62 \u0026micro;g/L (normal range: 1.1\u0026ndash;4.4), a hemoglobin A1c of 16,8%, as well as positive urinary ketones and glucosuria. Type 1 diabetes was assumed. The family history revealed a maternal cousin with type 1 diabetes and a maternal grandmother with type 2 diabetes. However, the immunological examination yielded absence of serum-autoantibodies against islet-cells (ICA), glutamic acid decarboxylase (GAD65), tyrosine phosphatase (IA-2), insulin (IAA) and zinc-transport-8 (ZnT8) in the affected patient (Tab. 1). The patient further reported that he had an asymptomatic COVID-19 (Sars-CoV-2) infection 6-8 weeks before when returning from vacations in Austria with his family. On April 29\u003csup\u003eth\u003c/sup\u003e 2020, he was tested positive for COVID-19 (Sars-CoV-2) IgG but not IgM indicating a previous COVID-19 infection.\u003c/p\u003e\n\u003cp\u003eThe patient needed treatment on the intensive care unit for 3 days for re-compensating DKA using intravenous insulin therapy according to international guidelines. At day 4, he was transferred to the endocrine ward and subcutaneous insulin therapy was initiated. In the course of the next days, blood glucose levels stabilized to 8.4 to 10.2 mmol/L (151 to 183 mg/dL). The patient received an educational program according to guidelines for type 1 diabetes management. He was discharged from hospital in good condition after 10 days.\u003c/p\u003e"},{"header":"Discussion","content":"\u003cp\u003eIt is known for several years that corona like viruses enter human cells via binding to membrane bound proteases \u003csup\u003e[1]\u003c/sup\u003e. For example, the Middle East Respiratory Syndrome virus (MERS-CoV), responsible for an outbreak of acute respiratory syndrome, has been shown to use dipeptidylpeptidase (DPP4)-4, a protease known to be involved in the regulation of the incretin system \u003csup\u003e[9]\u003c/sup\u003e. Recently, it has been demonstrated in a functional assay, that ACE2 acts as the major binding partner for COVID-19 (Sars-CoV-2) spike glycoprotein mediating host cell internalization \u003csup\u003e[10]\u003c/sup\u003e.\u003c/p\u003e\n\u003cp\u003eACE2 is widely expressed in eukaryotic cells membranes including those of pancreatic \u0026beta;-cells \u003csup\u003e[2]\u003c/sup\u003e. Using a high-fat diet mouse model it has been shown that \u0026beta;-cell dedifferentiation is accompanied by ACE2 reduction \u003csup\u003e[2]\u003c/sup\u003e. ACE2 deletion in NOD mice resulted in hyperglycemia, decreased \u0026beta;-cell insulin content and increased \u0026beta;-cell oxidative stress \u003csup\u003e[3]\u003c/sup\u003e. In addition, ACE2 deficiency reduced \u0026beta;-cell mass and impairs \u0026beta;-cell proliferation in obese C57BL/6 mice \u003csup\u003e[4]\u003c/sup\u003e, overall suggesting this glycoprotein to be important for \u0026beta;-cell homeostasis. Finally, it is currently under debate, that ACE2 is important for intra-islet paracrine mechanisms in the communication of \u0026alpha; and \u0026beta;-cells \u003csup\u003e[3]\u003c/sup\u003e.\u003c/p\u003e\n\u003cp\u003eThe hallmark in the pathology of classical type 1 diabetes is the \u0026beta;-cell destruction caused by a complex autoimmune process \u003csup\u003e[11]\u003c/sup\u003e. Environmental factors are suspected to be responsible, i.e. activating the immune system by reduction in gut microbiota, by early introduction to fruit or cow milk during childhood, by gluten, by toxins and especially by viruses \u003csup\u003e[12]\u003c/sup\u003e. Interestingly, besides inducing autoimmunity, some viruses like Enteroviruses might also exert direct cytolytic effects on pancreatic \u0026beta;-cell \u003csup\u003e[13]\u003c/sup\u003e.\u003c/p\u003e\n\u003cp\u003eThe patient reported here presented several weeks after a viral infection with a severe DKA with a profound loss of \u0026beta;-cell function. However, in contrast to the general idea that viral infections indirectly affect pancreatic \u0026beta;-cells by triggering autoimmunity, the absence of five typical antibodies in our patient might argue against classical autoimmune type 1 diabetes. Given the fact that ACE2 is expressed on pancreatic \u0026beta;-cells and ACE2 is the main receptor for COVID-19 (Sars-CoV-2) internalization we would like to propose a direct cytolytic \u0026beta;-cell damage due to COVID-19 (Sars-CoV-2) resulting in an insulin-depended diabetes without a classical autoimmune pathology in our patient. This assumption is supported by a recent mechanistic study demonstrating that adult human pancreatic alpha and beta cells are permissive to Sars-CoV-2 pseudo-entry virus and Sars-CoV-2 virus infection \u003csup\u003e[14]\u003c/sup\u003e. Furthermore, Sars-CoV-2 infection of pancreatic endocrine cells resulted in robust chemokine induction as seen in Covid-19 patients and upregulation of markers of cell death \u003csup\u003e[14]\u003c/sup\u003e. \u0026nbsp;\u003c/p\u003e\n\u003cp\u003eDespite a tremendous progress in biomedical research during the last centuries, the complex immunopathology of type 1 diabetes is still not elusively understood. A detailed understanding in the induction and progression of pancreatic \u0026beta;-cell failure, however, is crucial to develop novel innovative therapies to prevent and/or cure this important metabolic disease. In that regard, the detailed examination of patients developing \u0026beta;-cell failure and insulin-dependent diabetes after a COVID-19 infection in the future might yield novel insight into the yet unknown role of ACE2 in \u0026beta;-cell function and also possible virus induced cytolytic processes in type 1 diabetes development. Thus, a global registry has been launched to provide a systematic platform for collecting and analyzing these patients \u003csup\u003e[15]\u003c/sup\u003e. It will be critical to explore the frequency, severity and duration of these complications and to explore more deeply the mechanisms in primary human tissue. However, giving the fact that five different antibodies were tested negative our findings clearly suggest that diabetologists need to be aware of the possibility of an insulin dependent diabetes as an acute complication in COVID-19 (Sars-CoV-2) infected patients.\u003c/p\u003e"},{"header":"Research Design and Methods","content":"\u003cp\u003eThe patient reported here was treated at the Intensive Care Unit as well as the Division of Endocrinology, Diabetes and Clinical Nutrition at the Department of Medicine 1 at the University of Kiel, Germany. All authors were directly involved in the treatment of the patient. The patient provided written informed consent for the information presented in this Case Report to be published. Patient care and research were conducted in compliance with the Case Report guidelines and the Declaration of Helsinki.\u003c/p\u003e\n\u003cp\u003eBlood and urine samples (including autoantibodies against islet cells, GAD65, IA-2, insulin and ZnT8 in serum) were analyzed at the Department of Clinical Chemistry and Laboratory Medicine of the University of Kiel, Germany. Antibodies against COVID-19 (Sars-CoV-2) were determined by an external laboratory using the EDI\u0026trade; Novel Coronavirus COVID-19 IgG ELISA Kit (Epitope Diagnostics, San Diego, USA).\u003c/p\u003e"},{"header":"Declarations","content":"\u003cp\u003e\u003cstrong\u003eAcknowledgments:\u003c/strong\u003e\u003c/p\u003e\n\u003cp\u003eAuthor contributions: T.H. took cared of the patient on the ward and wrote the manuscript. D.M.S. took care of the patient in the emergency room and wrote the manuscript. A.G. took care of the patient on the intensive care unit and edited the manuscript, S.S. took care of the patient in the emergency room and wrote the manuscript. S.R.B. critically reviewed the case and wrote the manuscript.\u0026nbsp; M.L. took care of the patient on the ward and wrote the manuscript.\u003c/p\u003e\n\u003cp\u003e\u003cstrong\u003eStatement of guarantor:\u003c/strong\u003e\u003c/p\u003e\n\u003cp\u003eConflict-of-interest: Authors have no relevant conflict of interest to disclose.\u003c/p\u003e"},{"header":"References","content":"\u003cp\u003e[1] Hoffmann M, Kleine-Weber H, Schroeder S, Kr\u0026uuml;ger N, Herrler T, Erichsen S, Schiergens TS, Herrler G, Wu NH, Nitsche A, M\u0026uuml;ller MA, Drosten C, P\u0026ouml;hlmann S. SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor. \u003cem\u003eCell\u003c/em\u003e. 2020, \u003cstrong\u003e181\u003c/strong\u003e:271-280.e8\u003c/p\u003e\n\u003cp\u003e[2] Xuan X, Gao F, Ma X, Huang C, Wang Y, Deng H, Wang S, Li W, Yuanet L, Activation of ACE2/angiotensin (1\u0026ndash;7) attenuates pancreatic \u0026beta; cell dedifferentiation in a high-fat-diet mouse model, \u003cem\u003eMetabolism\u003c/em\u003e 2018, \u003cstrong\u003e81\u003c/strong\u003e:83-96\u003c/p\u003e\n\u003cp\u003e[3] Roca-Ho H, Palau V, Gimeno J, Pascual J, Soler MJ, Riera M, Angiotensin-converting enzyme 2 influences pancreatic and renal function in diabetic mice, \u003cem\u003eLab Invest,\u003c/em\u003e 2020, doi.org/10.1038/s41374-020-0440-5\u003c/p\u003e\n\u003cp\u003e[4] Shoemaker R, Yiannikouris F, Thatcher S, Cassis L: ACE2 deficiency reduces beta-cell mass and impairs beta-cell proliferation in obese C57BL/6 mice. \u003cem\u003eAm J Physiol Endocrinol Metab, \u003c/em\u003e2015, \u003cstrong\u003e309\u003c/strong\u003e:E621-631.\u003c/p\u003e\n\u003cp\u003e[5] Velavan, T., Meyer, C. The COVID-19 epidemic. \u003cem\u003eTropical medicine \u0026amp; international health\u003c/em\u003e, 2020, \u003cstrong\u003e3\u003c/strong\u003e:278\u0026ndash;280.\u003c/p\u003e\n\u003cp\u003e[6] Tay MZ, Poh CM, Renia L, MacAry PA, Ng LFP: The trinity of COVID-19: immunity, inflammation and intervention. \u003cem\u003eNat Rev Immunol\u003c/em\u003e. 2020 [epub ahead of print]. doi: 10.1038/s41577-020-0311-8\u003c/p\u003e\n\u003cp\u003e[7] Bornstein SR, Rubino F, Khunti K, Mingrone G, Hopkins D, Birkenfeld AL, Boehm B, Amiel S, Holt RIG, Skyler JS, DeVries JH, Renard E, Eckel RH, Zimmet P, Alberti KG, Vidal J, Geloneze B, Chan JC, Ji L, Ludwig B: Practical recommendations for the management of diabetes in patients with COVID-19. \u003cem\u003eLancet Diabetes Endocrinol\u003c/em\u003e. 2020, \u003cstrong\u003e8\u003c/strong\u003e: 546\u0026ndash;550. doi:\u0026nbsp;10.1016/S2213-8587(20)30152-2.\u003c/p\u003e\n\u003cp\u003e[8] Chee YJ, Huey Ng SJ, Yeoh E: Diabetic ketoacidosis precipitated by Covid-19 in a patient with newly diagnosed diabetes mellitus. \u003cem\u003eDiabetes Res Clin Pract\u003c/em\u003e. 2020; \u003cstrong\u003e164\u003c/strong\u003e: 108166. Published online 2020 Apr 24. doi:\u0026nbsp;10.1016/j.diabres.2020.108166\u003c/p\u003e\n\u003cp\u003e[9] Fleischer B. CD26: a surface protease involved in T-cell activation.\u0026nbsp;\u003cem\u003eImmunol Today\u003c/em\u003e.\u0026nbsp;1994, \u003cstrong\u003e15\u003c/strong\u003e:180\u0026ndash;184.\u0026nbsp;\u003c/p\u003e\n\u003cp\u003e[10] Letko M., Marzi A., Munster V. Functional assessment of cell entry and receptor usage for SARS-CoV-2 and other lineage B betacoronaviruses.\u0026nbsp;\u003cem\u003eNat Microbiol\u003c/em\u003e.\u0026nbsp;2020, \u003cstrong\u003e5\u003c/strong\u003e:562\u0026ndash;569.\u0026nbsp;\u003c/p\u003e\n\u003cp\u003e[11] Saberzadeh-Ardestani B, Karamzadeh R, Basiri M, Hajizadeh-Saffar E, Farhadi A, Shapiro AMJ, Tahamtani Y, Baharvand H: Type 1 Diabetes Mellitus: Cellular and Molecular Pathophysiology at A Glance. \u003cem\u003eCell J\u003c/em\u003e, 2018,\u003cstrong\u003e 20:\u003c/strong\u003e294-301.\u003c/p\u003e\n\u003cp\u003e[12] Knip M, Simell O: Environmental triggers of type 1 diabetes. \u003cem\u003eCold Spring Harb Perspect Med, \u003c/em\u003e2012, 2:a007690.\u003c/p\u003e\n\u003cp\u003e[13]\u003c/p\u003e\n\u003cp\u003eRodriguez-Calvo T, Sabouri S, Anquetil F, von Herrath MG: The viral paradigm in type 1 diabetes: Who are the main suspects? \u003cem\u003eAutoimmun Rev\u003c/em\u003e, 2016, \u003cstrong\u003e15\u003c/strong\u003e:964-969.\u003c/p\u003e\n\u003cp\u003e[14] Yang L, Han Y, Nilsson-Payant BE, Gupta V, Wang P, Duan X, Tang X, Zhu J, Zhao Z, Jaffr\u0026eacute; F, Tuo Zhang, Kim TW, Harschnitz O, Redmond D, Houghton S, Liu C, Naji A, Ciceri G, Guttikonda S, Bram Y, Nguyen DHT, Cioffi M, Chandar V, Hoagland DA, Huang Y, Xiang J, Wang H, Lyden D, Borczuk A, Chen HJ, Studer L, Pan FC, Ho DD, tenOever BR, Evans T, Schwartz RE, Chen S: A Human Pluripotent Stem Cell-based Platform to Study SARS-CoV-2 Tropism and Model Virus Infection in Human Cells and Organoids. \u003cem\u003eCell Stem Cell\u003c/em\u003e. doi:\u0026nbsp;10.1016/j.stem.2020.06.015\u003c/p\u003e\n\u003cp\u003e[15] Rubino F, Amiel SA, Zimmet P, Alberti G, Bornstein SR, Eckel RH, Mingrone G, Boehm B, Cooper ME, Chai Z, Del Prato S, Ji L, Hopkins D, Herman WH, Khunti K, Mbanya JC, Renard E: New-Onset Diabetes in Covid-19. \u003cem\u003eN Engl J Med\u003c/em\u003e. 2020: NEJMc2018688. Published online 2020 Jun 12. doi:\u0026nbsp;10.1056/NEJMc2018688\u003c/p\u003e"},{"header":"Tables","content":"\u003cp style=\"margin: 0in 0in 0.0001pt;font-family: Cambria, serif;line-height: 32px;\"\u003e\u003cstrong\u003e\u003cspan style=\"font-family: Verdana, Geneva, sans-serif; font-size: 11px; color: rgb(0, 0, 0);\"\u003eTable 1 \u0026ndash; Immune diagnostic\u0026nbsp;\u003c/span\u003e\u003c/strong\u003e\u003c/p\u003e\n\u003ctable border=\"1\" cellpadding=\"0\" cellspacing=\"0\" style=\"width: 334.2pt;border-collapse: collapse;border: none;\" width=\"446\"\u003e\n \u003ctbody\u003e\n \u003ctr\u003e\n \u003ctd style=\"width: 95.7pt;border: 1pt solid rgb(191, 191, 191);padding: 3.75pt 6pt;height: 0.95pt;vertical-align: top;\" valign=\"top\" width=\"28.699551569506728%\"\u003e\n \u003cp style=\"margin: 0in 0in 0.0001pt;font-size:16px;font-family: Cambria, serif;line-height: 32px;vertical-align: baseline;\"\u003e\u003cspan style=\"color: rgb(0, 0, 0);\"\u003e\u003cspan style=\"font-family: Verdana, Geneva, sans-serif;\"\u003e\u003cspan style=\"font-size: 11px;\"\u003e\u003cspan style=\"line-height: 26.666664123535156px;\"\u003e\u0026nbsp;\u003c/span\u003e\u003c/span\u003e\u003c/span\u003e\u003c/span\u003e\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd style=\"width: 116pt;border-top-width: 1pt;border-right-width: 1pt;border-bottom-width: 1pt;border-style: solid solid solid none;border-top-color: rgb(191, 191, 191);border-right-color: rgb(191, 191, 191);border-bottom-color: rgb(191, 191, 191);padding: 3.75pt 6pt;height: 0.95pt;vertical-align: top;\" valign=\"top\" width=\"34.75336322869955%\"\u003e\n \u003cp style=\"margin: 0in 0in 0.0001pt;font-size:16px;font-family: Cambria, serif;line-height: 32px;\"\u003e\u003cspan style=\"color: rgb(0, 0, 0);\"\u003e\u003cspan style=\"font-family: Verdana, Geneva, sans-serif;\"\u003e\u003cspan style=\"font-size: 11px;\"\u003e\u003cstrong\u003e\u003cspan style=\"line-height: 26.666664123535156px;\"\u003eResult\u003c/span\u003e\u003c/strong\u003e\u003c/span\u003e\u003c/span\u003e\u003c/span\u003e\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd style=\"width: 122.5pt;border-top-width: 1pt;border-right-width: 1pt;border-bottom-width: 1pt;border-style: solid solid solid none;border-top-color: rgb(191, 191, 191);border-right-color: rgb(191, 191, 191);border-bottom-color: rgb(191, 191, 191);padding: 0in 0in 0in 0.05in;height: 0.95pt;vertical-align: top;\" valign=\"top\" width=\"36.54708520179372%\"\u003e\n \u003cp style=\"margin: 0in 0in 0.0001pt;font-size:16px;font-family: Cambria, serif;line-height: 32px;\"\u003e\u003cspan style=\"color: rgb(0, 0, 0);\"\u003e\u003cspan style=\"font-family: Verdana, Geneva, sans-serif;\"\u003e\u003cspan style=\"font-size: 11px;\"\u003e\u003cstrong\u003e\u003cspan style=\"line-height: 26.666664123535156px;\"\u003eReference range\u003c/span\u003e\u003c/strong\u003e\u003c/span\u003e\u003c/span\u003e\u003c/span\u003e\u003c/p\u003e\n \u003c/td\u003e\n \u003c/tr\u003e\n \u003ctr\u003e\n \u003ctd style=\"width: 95.7pt;border-right-width: 1pt;border-bottom-width: 1pt;border-left-width: 1pt;border-style: none solid solid;border-right-color: rgb(191, 191, 191);border-bottom-color: rgb(191, 191, 191);border-left-color: rgb(191, 191, 191);padding: 3.75pt 6pt;height: 0.95pt;vertical-align: top;\" valign=\"top\" width=\"28.699551569506728%\"\u003e\n \u003cp style=\"margin: 0in 0in 0.0001pt;font-size:16px;font-family: Cambria, serif;line-height: 32px;vertical-align: baseline;\"\u003e\u003cspan style=\"color: rgb(0, 0, 0);\"\u003e\u003cspan style=\"font-family: Verdana, Geneva, sans-serif;\"\u003e\u003cspan style=\"font-size: 11px;\"\u003e\u003cspan style=\"line-height: 26.666664123535156px;\"\u003eGAD65-AA\u003c/span\u003e\u003c/span\u003e\u003c/span\u003e\u003c/span\u003e\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd style=\"width: 116pt;border-style: none solid solid none;border-bottom-width: 1pt;border-bottom-color: rgb(191, 191, 191);border-right-width: 1pt;border-right-color: rgb(191, 191, 191);padding: 3.75pt 6pt;height: 0.95pt;vertical-align: top;\" valign=\"top\" width=\"34.75336322869955%\"\u003e\n \u003cp style=\"margin: 0in 0in 0.0001pt;font-size:16px;font-family: Cambria, serif;line-height: 32px;\"\u003e\u003cspan style=\"color: rgb(0, 0, 0);\"\u003e\u003cspan style=\"font-family: Verdana, Geneva, sans-serif;\"\u003e\u003cspan style=\"font-size: 11px;\"\u003e\u003cspan style=\"line-height: 26.666664123535156px;\"\u003e\u0026lt; 5 IU/mL\u003c/span\u003e\u003c/span\u003e\u003c/span\u003e\u003c/span\u003e\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd style=\"width: 122.5pt;border-style: none solid solid none;border-bottom-width: 1pt;border-bottom-color: rgb(191, 191, 191);border-right-width: 1pt;border-right-color: rgb(191, 191, 191);padding: 0in 0in 0in 0.05in;height: 0.95pt;vertical-align: top;\" valign=\"top\" width=\"36.54708520179372%\"\u003e\n \u003cp style=\"margin: 0in 0in 0.0001pt;font-size:16px;font-family: Cambria, serif;line-height: 32px;\"\u003e\u003cspan style=\"color: rgb(0, 0, 0);\"\u003e\u003cspan style=\"font-family: Verdana, Geneva, sans-serif;\"\u003e\u003cspan style=\"font-size: 11px;\"\u003e\u003cspan style=\"line-height: 26.666664123535156px;\"\u003e\u0026lt; 10\u003c/span\u003e\u003c/span\u003e\u003c/span\u003e\u003c/span\u003e\u003c/p\u003e\n \u003c/td\u003e\n \u003c/tr\u003e\n \u003ctr\u003e\n \u003ctd style=\"width: 95.7pt;border-right-width: 1pt;border-bottom-width: 1pt;border-left-width: 1pt;border-style: none solid solid;border-right-color: rgb(191, 191, 191);border-bottom-color: rgb(191, 191, 191);border-left-color: rgb(191, 191, 191);padding: 3.75pt 6pt;height: 0.95pt;vertical-align: top;\" valign=\"top\" width=\"28.699551569506728%\"\u003e\n \u003cp style=\"margin: 0in 0in 0.0001pt;font-size:16px;font-family: Cambria, serif;line-height: 32px;vertical-align: baseline;\"\u003e\u003cspan style=\"color: rgb(0, 0, 0);\"\u003e\u003cspan style=\"font-family: Verdana, Geneva, sans-serif;\"\u003e\u003cspan style=\"font-size: 11px;\"\u003e\u003cspan style=\"line-height: 26.666664123535156px;\"\u003eIA-2-AA\u003c/span\u003e\u003c/span\u003e\u003c/span\u003e\u003c/span\u003e\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd style=\"width: 116pt;border-style: none solid solid none;border-bottom-width: 1pt;border-bottom-color: rgb(191, 191, 191);border-right-width: 1pt;border-right-color: rgb(191, 191, 191);padding: 3.75pt 6pt;height: 0.95pt;vertical-align: top;\" valign=\"top\" width=\"34.75336322869955%\"\u003e\n \u003cp style=\"margin: 0in 0in 0.0001pt;font-size:16px;font-family: Cambria, serif;line-height: 32px;vertical-align: baseline;\"\u003e\u003cspan style=\"color: rgb(0, 0, 0);\"\u003e\u003cspan style=\"font-family: Verdana, Geneva, sans-serif;\"\u003e\u003cspan style=\"font-size: 11px;\"\u003e\u003cspan style=\"line-height: 26.666664123535156px;\"\u003e\u0026lt; 10 IU/mL\u003c/span\u003e\u003c/span\u003e\u003c/span\u003e\u003c/span\u003e\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd style=\"width: 122.5pt;border-style: none solid solid none;border-bottom-width: 1pt;border-bottom-color: rgb(191, 191, 191);border-right-width: 1pt;border-right-color: rgb(191, 191, 191);padding: 0in 0in 0in 0.05in;height: 0.95pt;vertical-align: top;\" valign=\"top\" width=\"36.54708520179372%\"\u003e\n \u003cp style=\"margin: 0in 0in 0.0001pt;font-size:16px;font-family: Cambria, serif;line-height: 32px;\"\u003e\u003cspan style=\"color: rgb(0, 0, 0);\"\u003e\u003cspan style=\"font-family: Verdana, Geneva, sans-serif;\"\u003e\u003cspan style=\"font-size: 11px;\"\u003e\u003cspan style=\"line-height: 26.666664123535156px;\"\u003e\u0026lt; 10\u003c/span\u003e\u003c/span\u003e\u003c/span\u003e\u003c/span\u003e\u003c/p\u003e\n \u003c/td\u003e\n \u003c/tr\u003e\n \u003ctr\u003e\n \u003ctd style=\"width: 95.7pt;border-right-width: 1pt;border-bottom-width: 1pt;border-left-width: 1pt;border-style: none solid solid;border-right-color: rgb(191, 191, 191);border-bottom-color: rgb(191, 191, 191);border-left-color: rgb(191, 191, 191);padding: 3.75pt 6pt;height: 0.95pt;vertical-align: top;\" valign=\"top\" width=\"28.699551569506728%\"\u003e\n \u003cp style=\"margin: 0in 0in 0.0001pt;font-size:16px;font-family: Cambria, serif;line-height: 32px;vertical-align: baseline;\"\u003e\u003cspan style=\"color: rgb(0, 0, 0);\"\u003e\u003cspan style=\"font-family: Verdana, Geneva, sans-serif;\"\u003e\u003cspan style=\"font-size: 11px;\"\u003e\u003cspan style=\"line-height: 26.666664123535156px;\"\u003eIC-AA\u003c/span\u003e\u003c/span\u003e\u003c/span\u003e\u003c/span\u003e\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd style=\"width: 116pt;border-style: none solid solid none;border-bottom-width: 1pt;border-bottom-color: rgb(191, 191, 191);border-right-width: 1pt;border-right-color: rgb(191, 191, 191);padding: 3.75pt 6pt;height: 0.95pt;vertical-align: top;\" valign=\"top\" width=\"34.75336322869955%\"\u003e\n \u003cp style=\"margin: 0in 0in 0.0001pt;font-size:16px;font-family: Cambria, serif;line-height: 32px;vertical-align: baseline;\"\u003e\u003cspan style=\"color: rgb(0, 0, 0);\"\u003e\u003cspan style=\"font-family: Verdana, Geneva, sans-serif;\"\u003e\u003cspan style=\"font-size: 11px;\"\u003e\u003cspan style=\"line-height: 26.666664123535156px;\"\u003enegative\u003c/span\u003e\u003c/span\u003e\u003c/span\u003e\u003c/span\u003e\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd style=\"width: 122.5pt;border-style: none solid solid none;border-bottom-width: 1pt;border-bottom-color: rgb(191, 191, 191);border-right-width: 1pt;border-right-color: rgb(191, 191, 191);padding: 0in 0in 0in 0.05in;height: 0.95pt;vertical-align: top;\" valign=\"top\" width=\"36.54708520179372%\"\u003e\n \u003cp style=\"margin: 0in 0in 0.0001pt;font-size:16px;font-family: Cambria, serif;line-height: 32px;vertical-align: baseline;\"\u003e\u003cspan style=\"color: rgb(0, 0, 0);\"\u003e\u003cspan style=\"font-family: Verdana, Geneva, sans-serif;\"\u003e\u003cspan style=\"font-size: 11px;\"\u003e\u003cspan style=\"line-height: 26.666664123535156px;\"\u003enegative\u003c/span\u003e\u003c/span\u003e\u003c/span\u003e\u003c/span\u003e\u003c/p\u003e\n \u003c/td\u003e\n \u003c/tr\u003e\n \u003ctr\u003e\n \u003ctd style=\"width: 95.7pt;border-right-width: 1pt;border-bottom-width: 1pt;border-left-width: 1pt;border-style: none solid solid;border-right-color: rgb(191, 191, 191);border-bottom-color: rgb(191, 191, 191);border-left-color: rgb(191, 191, 191);padding: 3.75pt 6pt;height: 0.95pt;vertical-align: top;\" valign=\"top\" width=\"28.699551569506728%\"\u003e\n \u003cp style=\"margin: 0in 0in 0.0001pt;font-size:16px;font-family: Cambria, serif;line-height: 32px;vertical-align: baseline;\"\u003e\u003cspan style=\"color: rgb(0, 0, 0);\"\u003e\u003cspan style=\"font-family: Verdana, Geneva, sans-serif;\"\u003e\u003cspan style=\"font-size: 11px;\"\u003e\u003cspan style=\"line-height: 26.666664123535156px;\"\u003eI-AA\u003c/span\u003e\u003c/span\u003e\u003c/span\u003e\u003c/span\u003e\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd style=\"width: 116pt;border-style: none solid solid none;border-bottom-width: 1pt;border-bottom-color: rgb(191, 191, 191);border-right-width: 1pt;border-right-color: rgb(191, 191, 191);padding: 3.75pt 6pt;height: 0.95pt;vertical-align: top;\" valign=\"top\" width=\"34.75336322869955%\"\u003e\n \u003cp style=\"margin: 0in 0in 0.0001pt;font-size:16px;font-family: Cambria, serif;line-height: 32px;vertical-align: baseline;\"\u003e\u003cspan style=\"color: rgb(0, 0, 0);\"\u003e\u003cspan style=\"font-family: Verdana, Geneva, sans-serif;\"\u003e\u003cspan style=\"font-size: 11px;\"\u003e\u003cspan style=\"line-height: 26.666664123535156px;\"\u003e\u0026lt; 0.1 IU/mL\u003c/span\u003e\u003c/span\u003e\u003c/span\u003e\u003c/span\u003e\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd style=\"width: 122.5pt;border-style: none solid solid none;border-bottom-width: 1pt;border-bottom-color: rgb(191, 191, 191);border-right-width: 1pt;border-right-color: rgb(191, 191, 191);padding: 0in 0in 0in 0.05in;height: 0.95pt;vertical-align: top;\" valign=\"top\" width=\"36.54708520179372%\"\u003e\n \u003cp style=\"margin: 0in 0in 0.0001pt;font-size:16px;font-family: Cambria, serif;line-height: 32px;\"\u003e\u003cspan style=\"color: rgb(0, 0, 0);\"\u003e\u003cspan style=\"font-family: Verdana, Geneva, sans-serif;\"\u003e\u003cspan style=\"font-size: 11px;\"\u003e\u003cspan style=\"line-height: 26.666664123535156px;\"\u003e\u0026lt; 0.4\u003c/span\u003e\u003c/span\u003e\u003c/span\u003e\u003c/span\u003e\u003c/p\u003e\n \u003c/td\u003e\n \u003c/tr\u003e\n \u003ctr\u003e\n \u003ctd style=\"width: 95.7pt;border-right-width: 1pt;border-bottom-width: 1pt;border-left-width: 1pt;border-style: none solid solid;border-right-color: rgb(191, 191, 191);border-bottom-color: rgb(191, 191, 191);border-left-color: rgb(191, 191, 191);padding: 3.75pt 6pt;height: 0.95pt;vertical-align: top;\" valign=\"top\" width=\"28.699551569506728%\"\u003e\n \u003cp style=\"margin: 0in 0in 0.0001pt;font-size:16px;font-family: Cambria, serif;line-height: 32px;vertical-align: baseline;\"\u003e\u003cspan style=\"color: rgb(0, 0, 0);\"\u003e\u003cspan style=\"font-family: Verdana, Geneva, sans-serif;\"\u003e\u003cspan style=\"font-size: 11px;\"\u003e\u003cspan style=\"line-height: 26.666664123535156px;\"\u003eZnT8-AA\u003c/span\u003e\u003c/span\u003e\u003c/span\u003e\u003c/span\u003e\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd style=\"width: 116pt;border-style: none solid solid none;border-bottom-width: 1pt;border-bottom-color: rgb(191, 191, 191);border-right-width: 1pt;border-right-color: rgb(191, 191, 191);padding: 3.75pt 6pt;height: 0.95pt;vertical-align: top;\" valign=\"top\" width=\"34.75336322869955%\"\u003e\n \u003cp style=\"margin: 0in 0in 0.0001pt;font-size:16px;font-family: Cambria, serif;line-height: 32px;vertical-align: baseline;\"\u003e\u003cspan style=\"color: rgb(0, 0, 0);\"\u003e\u003cspan style=\"font-family: Verdana, Geneva, sans-serif;\"\u003e\u003cspan style=\"font-size: 11px;\"\u003e\u003cspan style=\"line-height: 26.666664123535156px;\"\u003e\u0026lt; 10 IU/mL\u003c/span\u003e\u003c/span\u003e\u003c/span\u003e\u003c/span\u003e\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd style=\"width: 122.5pt;border-style: none solid solid none;border-bottom-width: 1pt;border-bottom-color: rgb(191, 191, 191);border-right-width: 1pt;border-right-color: rgb(191, 191, 191);padding: 0in 0in 0in 0.05in;height: 0.95pt;vertical-align: top;\" valign=\"top\" width=\"36.54708520179372%\"\u003e\n \u003cp style=\"margin: 0in 0in 0.0001pt;font-size:16px;font-family: Cambria, serif;line-height: 32px;\"\u003e\u003cspan style=\"color: rgb(0, 0, 0);\"\u003e\u003cspan style=\"font-family: Verdana, Geneva, sans-serif;\"\u003e\u003cspan style=\"font-size: 11px;\"\u003e\u003cspan style=\"line-height: 26.666664123535156px;\"\u003e\u0026lt; 15\u003c/span\u003e\u003c/span\u003e\u003c/span\u003e\u003c/span\u003e\u003c/p\u003e\n \u003c/td\u003e\n \u003c/tr\u003e\n \u003ctr\u003e\n \u003ctd style=\"width: 95.7pt;border-right-width: 1pt;border-bottom-width: 1pt;border-left-width: 1pt;border-style: none solid solid;border-right-color: rgb(191, 191, 191);border-bottom-color: rgb(191, 191, 191);border-left-color: rgb(191, 191, 191);padding: 3.75pt 6pt;height: 0.95pt;vertical-align: top;\" valign=\"top\" width=\"28.699551569506728%\"\u003e\n \u003cp style=\"margin: 0in 0in 0.0001pt;font-size:16px;font-family: Cambria, serif;line-height: 32px;vertical-align: baseline;\"\u003e\u003cspan style=\"color: rgb(0, 0, 0);\"\u003e\u003cspan style=\"font-family: Verdana, Geneva, sans-serif;\"\u003e\u003cspan style=\"font-size: 11px;\"\u003e\u003cspan style=\"line-height: 26.666664123535156px;\"\u003eCOVID-19 (Sars-Cov-2) IgG\u003c/span\u003e\u003c/span\u003e\u003c/span\u003e\u003c/span\u003e\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd style=\"width: 116pt;border-style: none solid solid none;border-bottom-width: 1pt;border-bottom-color: rgb(191, 191, 191);border-right-width: 1pt;border-right-color: rgb(191, 191, 191);padding: 3.75pt 6pt;height: 0.95pt;vertical-align: top;\" valign=\"top\" width=\"34.75336322869955%\"\u003e\n \u003cp style=\"margin: 0in 0in 0.0001pt;font-size:16px;font-family: Cambria, serif;line-height: 32px;vertical-align: baseline;\"\u003e\u003cspan style=\"color: rgb(0, 0, 0);\"\u003e\u003cspan style=\"font-family: Verdana, Geneva, sans-serif;\"\u003e\u003cspan style=\"font-size: 11px;\"\u003e\u003cspan style=\"line-height: 26.666664123535156px;\"\u003epositive\u003c/span\u003e\u003c/span\u003e\u003c/span\u003e\u003c/span\u003e\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd style=\"width: 122.5pt;border-style: none solid solid none;border-bottom-width: 1pt;border-bottom-color: rgb(191, 191, 191);border-right-width: 1pt;border-right-color: rgb(191, 191, 191);padding: 0in 0in 0in 0.05in;height: 0.95pt;vertical-align: top;\" valign=\"top\" width=\"36.54708520179372%\"\u003e\n \u003cp style=\"margin: 0in 0in 0.0001pt;font-size:16px;font-family: Cambria, serif;line-height: 32px;\"\u003e\u003cspan style=\"color: rgb(0, 0, 0);\"\u003e\u003cspan style=\"font-family: Verdana, Geneva, sans-serif;\"\u003e\u003cspan style=\"font-size: 11px;\"\u003e\u003cspan style=\"line-height: 26.666664123535156px;\"\u003e\u0026nbsp;\u003c/span\u003e\u003c/span\u003e\u003c/span\u003e\u003c/span\u003e\u003c/p\u003e\n \u003cp style=\"margin: 0in 0in 0.0001pt;font-size:16px;font-family: Cambria, serif;line-height: 32px;\"\u003e\u003cspan style=\"color: rgb(0, 0, 0);\"\u003e\u003cspan style=\"font-family: Verdana, Geneva, sans-serif;\"\u003e\u003cspan style=\"font-size: 11px;\"\u003e\u003cspan style=\"line-height: 26.666664123535156px;\"\u003enegative\u003c/span\u003e\u003c/span\u003e\u003c/span\u003e\u003c/span\u003e\u003c/p\u003e\n \u003c/td\u003e\n \u003c/tr\u003e\n \u003ctr\u003e\n \u003ctd style=\"width: 95.7pt;border-right-width: 1pt;border-bottom-width: 1pt;border-left-width: 1pt;border-style: none solid solid;border-right-color: rgb(191, 191, 191);border-bottom-color: rgb(191, 191, 191);border-left-color: rgb(191, 191, 191);padding: 3.75pt 6pt;height: 0.95pt;vertical-align: top;\" valign=\"top\" width=\"28.699551569506728%\"\u003e\n \u003cp style=\"margin: 0in 0in 0.0001pt;font-size:16px;font-family: Cambria, serif;line-height: 32px;vertical-align: baseline;\"\u003e\u003cspan style=\"color: rgb(0, 0, 0);\"\u003e\u003cspan style=\"font-family: Verdana, Geneva, sans-serif;\"\u003e\u003cspan style=\"font-size: 11px;\"\u003e\u003cspan style=\"line-height: 26.666664123535156px;\"\u003eCOVID-19 (Sars-Cov-2) IgM\u003c/span\u003e\u003c/span\u003e\u003c/span\u003e\u003c/span\u003e\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd style=\"width: 116pt;border-style: none solid solid none;border-bottom-width: 1pt;border-bottom-color: rgb(191, 191, 191);border-right-width: 1pt;border-right-color: rgb(191, 191, 191);padding: 3.75pt 6pt;height: 0.95pt;vertical-align: top;\" valign=\"top\" width=\"34.75336322869955%\"\u003e\n \u003cp style=\"margin: 0in 0in 0.0001pt;font-size:16px;font-family: Cambria, serif;line-height: 32px;vertical-align: baseline;\"\u003e\u003cspan style=\"color: rgb(0, 0, 0);\"\u003e\u003cspan style=\"font-family: Verdana, Geneva, sans-serif;\"\u003e\u003cspan style=\"font-size: 11px;\"\u003e\u003cspan style=\"line-height: 26.666664123535156px;\"\u003enegative\u003c/span\u003e\u003c/span\u003e\u003c/span\u003e\u003c/span\u003e\u003c/p\u003e\n \u003c/td\u003e\n \u003ctd style=\"width: 122.5pt;border-style: none solid solid none;border-bottom-width: 1pt;border-bottom-color: rgb(191, 191, 191);border-right-width: 1pt;border-right-color: rgb(191, 191, 191);padding: 0in 0in 0in 0.05in;height: 0.95pt;vertical-align: top;\" valign=\"top\" width=\"36.54708520179372%\"\u003e\n \u003cp style=\"margin: 0in 0in 0.0001pt;font-size:16px;font-family: Cambria, serif;line-height: 32px;\"\u003e\u003cspan style=\"color: rgb(0, 0, 0);\"\u003e\u003cspan style=\"font-family: Verdana, Geneva, sans-serif;\"\u003e\u003cspan style=\"font-size: 11px;\"\u003e\u003cspan style=\"line-height: 26.666664123535156px;\"\u003e\u0026nbsp;\u003c/span\u003e\u003c/span\u003e\u003c/span\u003e\u003c/span\u003e\u003c/p\u003e\n \u003cp style=\"margin: 0in 0in 0.0001pt;font-size:16px;font-family: Cambria, serif;line-height: 32px;\"\u003e\u003cspan style=\"color: rgb(0, 0, 0);\"\u003e\u003cspan style=\"font-family: Verdana, Geneva, sans-serif;\"\u003e\u003cspan style=\"font-size: 11px;\"\u003e\u003cspan style=\"line-height: 26.666664123535156px;\"\u003enegative\u003c/span\u003e\u003c/span\u003e\u003c/span\u003e\u003c/span\u003e\u003c/p\u003e\n \u003c/td\u003e\n \u003c/tr\u003e\n \u003c/tbody\u003e\n\u003c/table\u003e\n\u003cp style=\"margin: 0in 0in 10pt;font-family: Cambria, serif;text-align: justify;line-height: 32px;\"\u003e\u003cspan style=\"color: rgb(0, 0, 0);\"\u003e\u003cspan style=\"font-family: Verdana, Geneva, sans-serif;\"\u003e\u003cspan style=\"font-size: 11px;\"\u003eI-AA, insulin autoantibodies; IC-AA,\u0026nbsp;\u003c/span\u003e\u003c/span\u003e\u003c/span\u003e\u003cspan style=\"font-family: Verdana, Geneva, sans-serif; font-size: 11px; color: rgb(0, 0, 0);\"\u003eislet-cell autoantibodies; GAD65-AA, glutamic acid decarboxylase autoantibodies; IA-2-AA, tyrosine phosphatase autoantibodies; ZnT8-AA, zinc-transport-8 autoantibodies.\u003c/span\u003e\u003c/p\u003e"}],"fulltextSource":"","fullText":"","funders":[],"hasAdminPriorityOnWorkflow":false,"hasManuscriptDocX":true,"hasOptedInToPreprint":true,"hasPassedJournalQc":"","hasAnyPriority":true,"hideJournal":true,"highlight":"","institution":"","isAcceptedByJournal":false,"isAuthorSuppliedPdf":false,"isDeskRejected":"","isHiddenFromSearch":false,"isInQc":false,"isInWorkflow":false,"isPdf":false,"isPdfUpToDate":true,"isWithdrawnOrRetracted":false,"journal":{"display":true,"email":"[email protected]","identity":"researchsquare","isNatureJournal":false,"hasQc":true,"allowDirectSubmit":true,"externalIdentity":"","sideBox":"","snPcode":"","submissionUrl":"/submission","title":"Research Square","twitterHandle":"researchsquare","acdcEnabled":true,"dfaEnabled":false,"editorialSystem":"","reportingPortfolio":"","inReviewEnabled":false,"inReviewRevisionsEnabled":true},"keywords":"type 1 diabetes, COVID-19","lastPublishedDoi":"10.21203/rs.3.rs-39343/v1","lastPublishedDoiUrl":"https://doi.org/10.21203/rs.3.rs-39343/v1","license":{"name":"CC BY 4.0","url":"https://creativecommons.org/licenses/by/4.0/"},"manuscriptAbstract":"\u003cp\u003eHere we report the manifestation of insulin dependent diabetes after a COVID-19 infection in the absence of typical autoantibodies for type 1 diabetes. A 19-year-old Caucasian male subject presented to our emergency department with diabetic ketoacidosis (DKA). C-peptide levels accounted to 0.62µg/L in the presence of blood glucose concentrations of 30.6 mmol/L (552 mg/dL). The patient´s case history revealed a COVID-19 disease 6-8 weeks prior to admission. This is of interest, since COVID-19 internalization into host cells is mediated via Angiotensin-converting enzyme 2 (ACE2) \u003csup\u003e[1]\u003c/sup\u003e, a transmembrane glycoprotein which amongst others is crucial for β-cell homeostasis and function \u003csup\u003e[2,3,4]\u003c/sup\u003e. Detailed laboratory testing was performed, revealing no serum-antibodies against islet-cells (ICA), glutamic acid decarboxylase (GAD65-AA), tyrosine phosphatase (IA-2-AA), insulin (IAA) and zinc-transport-8 (ZnT8-AA), but against COVID-19. Hence, this is a presentation of an insulin-dependent diabetes mellitus in the absence of markers of autoimmunity, which might suggest direct cytolytic effects of COVID-19 on pancreatic β-cells presumably mediated via ACE2.\u003c/p\u003e\u003cp\u003e\u003cbr\u003e\u003c/p\u003e","manuscriptTitle":"Autoantibody-negative insulin-dependent Diabetes after COVID-19","msid":"","msnumber":"","nonDraftVersions":[{"code":1,"date":"2020-07-02 10:48:22","doi":"10.21203/rs.3.rs-39343/v1","editorialEvents":[{"type":"communityComments","content":0}],"status":"published","journal":{"display":true,"email":"[email protected]","identity":"researchsquare","isNatureJournal":false,"hasQc":true,"allowDirectSubmit":true,"externalIdentity":"","sideBox":"","snPcode":"","submissionUrl":"/submission","title":"Research Square","twitterHandle":"researchsquare","acdcEnabled":true,"dfaEnabled":false,"editorialSystem":"","reportingPortfolio":"","inReviewEnabled":false,"inReviewRevisionsEnabled":true}}],"origin":"","ownerIdentity":"899965ae-377a-47f5-aa7c-4cf2f55f32bd","owner":[],"postedDate":"July 2nd, 2020","published":true,"recentEditorialEvents":[],"rejectedJournal":[],"revision":"","amendment":"","status":"posted","subjectAreas":[{"id":137749,"name":"Endocrinology \u0026 Metabolism"}],"tags":[],"updatedAt":"2020-07-02T10:48:22+00:00","versionOfRecord":[],"versionCreatedAt":"2020-07-02 10:48:22","video":"","vorDoi":"","vorDoiUrl":"","workflowStages":[]},"version":"v1","identity":"rs-39343","journalConfig":"researchsquare"},"__N_SSP":true},"page":"/article/[identity]/[[...version]]","query":{"redirect":"/article/rs-39343","identity":"rs-39343","version":["v1"]},"buildId":"7rjqhiLT3MXkJMwkYKINL","isFallback":false,"isExperimentalCompile":false,"dynamicIds":[84888],"gssp":true,"scriptLoader":[]}

Text is read by the "Ask this paper" AI Q&A widget below. Extraction quality varies by source — PMC NXML preserves structure cleanly, OA-HTML may include some navigation residue, and OA-PDF can have broken hyphenation. The publisher copy (via DOI) is the canonical version.

My notes (saved in your browser only)

Ask this paper AI returns verbatim quotes from the full text · source: preprint-html

Answers must be backed by verbatim quotes from this paper's full text. Hallucinated quotes are dropped automatically; if no verbatim passage answers the question, we say so. How this works

Citation neighborhood (no data yet)

We don't have any in-corpus citations linked to this paper yet. The paper's references may be in our DB but unresolved to ``paper_id`` (resolution happens at ingest when the cited DOI matches a row we already have). Run the cross-source citation reconcile pass to retry.

Source provenance

europepmc
last seen: 2026-05-19T01:45:01.086888+00:00
unpaywall
last seen: 2026-05-21T05:10:58.409756+00:00
License: CC-BY-4.0